Drug intelligence / Profile preview

AC Vax

Development stage
Discontinued
Lead developer
GSK
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular, Subcutaneous
01

Overview

**AC Vax** was a GSK non-conjugated bivalent meningococcal polysaccharide vaccine formulated from capsular polysaccharide antigens of *Neisseria meningitidis* serogroups A and C. It was used for active immunization to prevent invasive meningococcal disease, including meningococcal meningitis and septicemia caused by these serogroups. The vaccine induces serogroup-specific anti-capsular antibody responses; as an unconjugated polysaccharide vaccine, it does not use a carrier protein. It was supplied as powder and solvent for solution for injection and administered intramuscularly or subcutaneously. The UK medicinal-product record identifies AC Vax as discontinued.

Brand names
AC Vax
Other names
Meningococcal polysaccharide A and C vaccine
02

Targets

Neisseria meningitidis group C capsular polysaccharideNmA CPS (Neisseria meningitidis group A capsular polysaccharide)

Beyond the preview

Go deeper on AC Vax.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AC Vax.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call